Montelukast Intermediate Market Research Report Information by Application (Asthma, Allergic Rhinitis, Bronchospasm and Urticaria) - Forecast till 2032

1 Executive Summary

1.1 Market Attractiveness Analysis 13

2 Market Introduction

2.1 Definition 15

2.2 Scope Of The Study 15

2.3 Assumptions 15

2.4 Market Structure 15

3 Research Methodology

3.1 Research Process 16

3.2 Primary Research 17

3.3 Secondary Research 18

3.4 Market Size Estimation 19

3.5 Forecast Model 19

4 Market Dynamics

4.1 Introduction 20

4.2 Drivers 21

4.2.1 Worldwide Rising Prevalence Of Asthma, Bronchospasm, Allergic Rhinitis, And Urticaria 21

4.2.2 Burgeoning Pharmaceutical Industry Coupled With The Growing Demand From API Manufacturers 21

4.2.3 Montelukast Patent Expiration Along With The Increasing Presence Of Generics 22

4.3 Restraints 22

4.3.1 Presence Of Stringent Regulatory Policies 22

4.3.2 High Cost Of Manufacturing Building Blocks For APIs 22

4.4 Opportunity 23

4.4.1 Ongoing Research And Development Activities 23

5 Market Factor Analysis

5.1 Value Chain Analysis 24

5.1.1 Raw Material Sourcing 25

5.1.2 Manufacturing 25

5.1.3 Distribution & Sales 25

5.1.4 End Users 25

5.2 Porter’s Five Forces Model 26

5.2.1 Threat Of New Entrants 26

5.2.2 Bargaining Power Of Suppliers 27

5.2.3 Bargaining Power Of Buyers 27

5.2.4 Threat Of Substitutes 27

5.2.5 Intensity Of Rivalry 27

5.3 Investment Opportunities 28

5.4 Pricing Analysis 28

5.5 Clinical Trials 28

5.5.1 Overview 28

5.6 Patent Analysis 32

5.7 Regulatory Scenario 33

6 Montelukast Intermediate Market, By Application

6.1 Overview 34

6.2 Asthma 37

6.3 Allergic Rhinitis 38

6.4 Bronchospasm 39

6.5 Urticaria 40

7 Global Montelukast Intermediate Market, By Region

7.1 Overview 41

7.2 Americas 43

Montelukast Intermediate Market, By Application

7.2.1 North America 45

Montelukast Intermediate Market, By Application

7.2.1.1 US 46

Montelukast Intermediate Market, By Application

7.2.1.2 Canada 46

Montelukast Intermediate Market, By Application

7.2.2 Latin America 47

Montelukast Intermediate Market, By Application

7.3 Europe 48

Montelukast Intermediate Market, By Application

7.3.1 Western Europe 50

Montelukast Intermediate Market, By Application

7.3.1.1 UK 51

Montelukast Intermediate Market, By Application

7.3.1.2 France 51

Montelukast Intermediate Market, By Application

7.3.1.3 Spain 52

Montelukast Intermediate Market, By Application

7.3.1.4 Germany 52

Montelukast Intermediate Market, By Application

7.3.1.5 Italy 53

Montelukast Intermediate Market, By Application

7.3.1.6 Rest Of Western Europe 53

Montelukast Intermediate Market, By Application

7.3.2 Eastern Europe 54

Montelukast Intermediate Market, By Application

7.4 Asia-Pacific 55

Montelukast Intermediate Market, By Application

7.4.1 China 57

Montelukast Intermediate Market, By Application

7.4.2 India 57

Montelukast Intermediate Market, By Application

7.4.3 Japan 58

Montelukast Intermediate Market, By Application

7.4.4 Rest Of Asia-Pacific 58

Montelukast Intermediate Market, By Application

7.5 Middle East & Africa 59

Montelukast Intermediate Market, By Application

7.5.1 Middle East 61

Montelukast Intermediate Market, By Application

7.5.2 Africa 61

Montelukast Intermediate Market, By Application

8 Competitive Landscape

8.1 Introduction 62

8.2 Major Players In The Global Montelukast Intermediate Market 62

9 Company Profiles

9.1 VIVAN Life Sciences 63

9.1.1 Financial Overview 63

9.1.2 Products/Services Offered 63

9.1.3 Key Developments 63

9.1.4 SWOT Analysis 64

9.1.5 Key Strategies 64

9.2 P.G. Shah & Co. 65

9.2.1 Company Overview 65

9.2.2 Financial Overview 65

9.2.3 Products/Services Offered 65

9.2.4 Key Developments 65

9.2.5 SWOT Analysis 65

9.2.6 Key Strategies 66

9.3 Manus Aktteva Biopharma LLP 67

9.3.1 Company Overview 67

9.3.2 Financial Overview 67

9.3.3 Products/Services Offered 67

9.3.4 Key Developments 67

9.3.5 SWOT Analysis 67

9.3.6 Key Strategies 68

9.4 Ortin Laboratories Limited 69

9.4.1 Company Overview 69

9.4.2 Financial Overview 69

9.4.3 Products/Services Offered 69

9.4.4 Key Developments 69

9.4.5 SWOT Analysis 70

9.4.6 Key Strategies 70

10 Appendix

10.1 References 71

10.2 Related Reports 71

11 List Of Tables

TABLE 1 CLINICAL TRIALS 28

TABLE 2 GLOBAL MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 35

TABLE 3 GLOBAL MONTELUKAST INTERMEDIATE MARKET VOLUME, BY APPLICATION, 2020–2027 (KG) 36

TABLE 4 GLOBAL MONTELUKAST INTERMEDIATE MARKET, FOR ASTHMA, BY REGION, 2020–2027 (USD THOUSAND) 37

TABLE 5 GLOBAL MONTELUKAST INTERMEDIATE MARKET, FOR ALLERGIC RHINITIS, BY REGION, 2020–2027 (USD THOUSAND) 38

TABLE 6 GLOBAL MONTELUKAST INTERMEDIATE MARKET, FOR BRONCHOSPASM, BY REGION, 2020–2027 (USD THOUSAND) 39

TABLE 7 GLOBAL MONTELUKAST INTERMEDIATE MARKET, FOR URTICARIA, BY REGION, 2020–2027 (USD THOUSAND) 40

TABLE 8 GLOBAL MONTELUKAST INTERMEDIATE MARKET, BY REGION, 2020–2027 (USD THOUSAND) 42

TABLE 9 AMERICAS: MONTELUKAST INTERMEDIATE MARKET, BY REGION, 2020–2027 (USD THOUSAND) 43

TABLE 10 AMERICAS: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 44

TABLE 11 AMERICAS: MONTELUKAST INTERMEDIATE MARKET VOLUME, BY APPLICATION, 2020–2027 (KG) 44

TABLE 12 NORTH AMERICA: MONTELUKAST INTERMEDIATE MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 45

TABLE 13 NORTH AMERICA: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 45

TABLE 14 US: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 46

TABLE 15 CANADA: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 46

TABLE 16 LATIN AMERICA: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 47

TABLE 17 EUROPE: MONTELUKAST INTERMEDIATE MARKET, BY REGION, 2020–2027 (USD THOUSAND) 48

TABLE 18 EUROPE: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 49

TABLE 19 EUROPE: MONTELUKAST INTERMEDIATE MARKET VOLUME, BY APPLICATION, 2020–2027 (KG) 49

TABLE 20 WESTERN EUROPE: MONTELUKAST INTERMEDIATE MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 50

TABLE 21 WESTERN EUROPE: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 50

TABLE 22 UK: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 51

TABLE 23 FRANCE: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 51

TABLE 24 SPAIN: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 52

TABLE 25 GERMANY: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 52

TABLE 26 ITALY: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 53

TABLE 27 REST OF WESTERN EUROPE: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 53

TABLE 28 EASTERN EUROPE: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 54

TABLE 29 ASIA-PACIFIC: MONTELUKAST INTERMEDIATE MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND) 55

TABLE 30 ASIA-PACIFIC: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 56

TABLE 31 ASIA-PACIFIC: MONTELUKAST INTERMEDIATE MARKET VOLUME, BY APPLICATION, 2020–2027 (KG) 56

TABLE 32 CHINA: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 57

TABLE 33 INDIA: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 57

TABLE 34 JAPAN: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 58

TABLE 35 REST OF ASIA-PACIFIC: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 58

TABLE 36 MIDDLE EAST & AFRICA: MONTELUKAST INTERMEDIATE MARKET, BY REGION, 2020–2027 (USD THOUSAND) 59

TABLE 37 MIDDLE EAST & AFRICA: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 60

TABLE 38 MIDDLE EAST & AFRICA: MONTELUKAST INTERMEDIATE MARKET VOLUME, BY APPLICATION, 2020–2027 (KG) 60

TABLE 39 MIDDLE EAST: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 61

TABLE 40 MIDDLE EAST: MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND) 61

12 List Of Figures

FIGURE 1 MARKET SYNOPSIS 12

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL MONTELUKAST INTERMEDIATE MARKET 13

FIGURE 3 GLOBAL MONTELUKAST INTERMEDIATE MARKET SHARE, BY APPLICATION, 2027 (%) 13

FIGURE 4 GLOBAL MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020–2027 (USD THOUSANDS) 14

FIGURE 5 GLOBAL MONTELUKAST INTERMEDIATE MARKET: MARKET STRUCTURE 15

FIGURE 6 RESEARCH PROCESS OF MRFR 16

FIGURE 7 TOP-DOWN & BOTTOM-UP APPROACH 19

FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL MONTELUKAST INTERMEDIATE MARKET 20

FIGURE 9 VALUE CHAIN: GLOBAL MONTELUKAST INTERMEDIATE MARKET 24

FIGURE 10 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL MONTELUKAST INTERMEDIATE MARKET 26

FIGURE 11 GLOBAL MONTELUKAST INTERMEDIATE MARKET SHARE, BY APPLICATION, 2027 (%) 34

FIGURE 12 GLOBAL MONTELUKAST INTERMEDIATE MARKET, BY APPLICATION, 2020 & 2027 (USD THOUSAND) 35

FIGURE 13 GLOBAL MONTELUKAST INTERMEDIATE MARKET SHARE, BY REGION, 2027 (%) 41

FIGURE 14 GLOBAL MONTELUKAST INTERMEDIATE MARKET, BY REGION, 2020 & 2027 (USD THOUSAND) 42

FIGURE 15 AMERICAS: MONTELUKAST INTERMEDIATE MARKET SHARE, BY REGION, 2027 (%) 43

FIGURE 16 EUROPE: MONTELUKAST INTERMEDIATE MARKET SHARE, BY REGION, 2027 (%) 48

FIGURE 17 ASIA-PACIFIC: MONTELUKAST INTERMEDIATE MARKET SHARE, BY COUNTRY, 2027 (%) 55

FIGURE 18 MIDDLE EAST & AFRICA: MONTELUKAST INTERMEDIATE MARKET SHARE, BY REGION, 2027 (%) 59